On September 29, the Parliamentary Assembly of the Council of Europe adopted Resolution 2071  entitled “Public health and the interests of the pharmaceutical industry: how to guarantee the supremacy of public health interests.”

In particular, the Assembly calls on the Council of Member States in Europe to:

• Include special mandatory training in the curriculum for healthcare professionals to raise awareness of the impact of pharmaceutical promotion and ways to respond to it;
• Introduce a mandatory fee for the promotional activities of the pharmaceutical industry and use it, in particular, to finance the public fund, for the independent training of health care specialists;
• To impose an obligation on pharmaceutical companies to declare their interests related to all players in the health sector, to make these declarations available to the public, and to create an independent body responsible for monitoring this issue.”